Why is Thyrocare Tech. falling/rising?

As of 13-Nov, Thyrocare Technologies Ltd is experiencing a price increase, with its current price at 1,492.55, reflecting a rise of 93.85 or 6.71%. The stock has recently hit a new 52-week and all-time high of Rs 1558.35, demonstrating strong performance today by outperforming its sector by 6.94%. Over the past week, the stock has gained 12.81%, and in the last month, it has increased by 18.17%. The company has shown impressive financial results, including a net profit growth of 77.95% and positive results for the last seven consecutive quarters, contributing to its strong upward momentum. However, there are concerns regarding its high valuation and the fact that 85.84% of promoter shares are pledged, which could pose risks in a declining market.
In the broader market context, Thyrocare Technologies Ltd has significantly outperformed the Sensex, which has only increased by 1.40% over the past week, while Thyrocare's returns have been much higher at 12.81%. This stark contrast highlights the stock's strong market position and investor confidence despite some underlying risks. The stock's liquidity remains adequate, although there has been a decline in delivery volume, indicating a potential decrease in investor participation. Overall, the combination of strong financial performance and market-beating returns has driven the stock's recent rise, even as it faces challenges related to its valuation and promoter share pledges.